Observations placeholder
Optivar
Identifier
019813
Type of Spiritual Experience
Number of hallucinations: 8
Background
A description of the experience
Azelastine is a potent, second-generation, selective, histamine antagonist (histamine-H1-receptor antagonist) used a first line therapy of mild intermittent, moderate/severe intermittent and mild persistent rhinitis (new classification system for rhinitis).
Azelastine has been formulated both as a nasal spray and as eye drops and are available worldwide under many brand names
On Jan, 28, 2016: 163 people reported to have side effects when taking Optivar. Among them, 3 people (1.84%) have Hallucination.
On Jan, 13, 2016: 223 people reported to have side effects when taking Azelastine hydrochloride. Among them, 5 people (2.24%) have Hallucination.
On Jan, 28, 2016: 163 people reported to have side effects when taking Optivar. Among them, 1 people (0.61%) has Death.